Clinical trials of CD19-targeted CAR-modified T cell therapy; a complex and varied landscape.
a Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.|b Department of Medicine , University of Washington , Seattle , WA , USA.
Cameron J
CJ
Turtle
a Clinical Research Division , Fred Hutchinson Cancer Research Center , Seattle , WA , USA.|b Department of Medicine , University of Washington , Seattle , WA , USA.
David G
DG
Maloney
D018941:Antigens, CD19; D064987:Cell- and Tissue-Based Therapy; D002986:Clinical Trials as Topic; D006801:Humans; D016219:Immunotherapy, Adoptive; D011948:Receptors, Antigen, T-Cell; D051603:Recoverin
D018941:Antigens, CD19; C496731:RCVRN protein, human; D011948:Receptors, Antigen, T-Cell; D051603:Recoverin
Chimeric antigen receptor; T cells; acute lymphoblastic leukemia; cellular therapy; chronic lymphocytic leukemia; immunotherapy; non-Hodgkin lymphoma